The University of Chicago Header Logo

Connection

Mark Kozloff to Oligonucleotides, Antisense

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Oligonucleotides, Antisense.
Mark Kozloff
Connection Strength
0.015
Oligonucleotides, Antisense
  1. Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer. J Clin Oncol. 2004 Mar 15; 22(6):1110-7.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.